Wiskott Aldrich syndrome is characterized by all Except:
**Question:** Wiskott Aldrich syndrome is characterized by all Except:
A. Autoimmune disorders
B. Hemolytic anemia
C. Severe eczema
D. Infections
**Core Concept:**
Wiskott-Aldrich syndrome (WAS) is a rare primary immunodeficiency disorder characterized by a deficiency in the WAS protein, which is encoded by the WAS gene on chromosome X. The WAS protein is crucial for the proper functioning of immune cells, particularly T-cells and B-cells, and is involved in cell adhesion, cytoskeleton organization, and immune synapse formation.
**Why the Correct Answer is Right:**
Option A (Autoimmune disorders) is correct because, despite the increased susceptibility to infections in WAS patients, autoimmune disorders are not a hallmark feature of the syndrome. WAS patients typically do not develop autoimmune diseases, reflecting the importance of the WAS protein in maintaining immune tolerance.
Option B (Hemolytic anemia) is incorrect because WAS primarily affects immune function, and hemolytic anemia is not a common feature of the syndrome. WAS patients usually present with recurrent infections, eczema, and thrombocytopenia, rather than hemolytic anemia.
Option C (Severe eczema) is correct because one of the key clinical features of Wiskott-Aldrich syndrome is severe eczema (dermatitis) due to impaired immune cell function and increased exposure to skin-damaging irritants.
Option D (Infections) is correct because WAS patients have a defect in the immune system that results in recurrent, severe, and often life-threatening bacterial infections. The deficiency in WAS protein impairs the immune cells' ability to adhere, migrate, and function effectively, leading to increased susceptibility to infections.
**Why Each Wrong Option is Incorrect:**
Option A (Autoimmune disorders) is incorrect because WAS primarily affects immune function, and autoimmune diseases are not a common feature of the syndrome. WAS patients typically do not develop autoimmune diseases, reflecting the importance of the WAS protein in maintaining immune tolerance.
Option B (Hemolytic anemia) is incorrect because WAS primarily affects immune function, and hemolytic anemia is not a common feature of the syndrome. WAS patients usually present with recurrent infections, eczema, and thrombocytopenia, rather than hemolytic anemia.
Option C (Severe eczema) is incorrect because Wiskott-Aldrich syndrome is characterized by severe eczema (dermatitis), which is a clinical manifestation of impaired immune cell function and increased exposure to skin-damaging irritants.
Option D (Infections) is incorrect because WAS patients have a defect in the immune system that results in recurrent, severe, and often life-threatening bacterial infections. The deficiency in WAS protein impairs the immune cells' ability to adhere, migrate, and function effectively, leading to increased susceptibility to infections.